58 articles
Kenneth G. Saag
Kenneth G. Saag is an American rheumatologist and outcomes researcher at the University of Alabama at Birmingham, known for osteoporosis trials and as the 85th President of the American College of Rheumatology.
Lars Klareskog
Lars Klareskog, born 1945, is a Swedish rheumatology researcher at Karolinska Institutet who showed how smoking and HLA-DR genes trigger immunity to citrullinated proteins in rheumatoid arthritis, and led the 2004 TEMPO trial.
Lionel B. Ivashkiv
Lionel B. Ivashkiv is an American physician-scientist and rheumatologist who studies cytokine signaling and macrophage biology, and is Chief Scientific Officer at the Hospital for Special Surgery in New York.
Maarten Boers
Maarten Boers is a Dutch rheumatologist and clinical epidemiologist, full professor at Amsterdam UMC and a rheumatologist at Reade, known for the 1997 COBRA trial and co-founding OMERACT.
Mark C. Genovese
Mark C. Genovese is an American rheumatologist who spent over two decades at Stanford leading phase 3 trials of rheumatoid arthritis drugs, then joined Gilead Sciences in 2020.
Martin Lotz
Martin Lotz, also known as Martin K. Lotz, is a German-born physician-scientist in rheumatology at The Scripps Research Institute known for work on joint aging and osteoarthritis.
Maxime Dougados
Maxime Dougados is a French rheumatologist, professor at Université Paris Cité, who led rheumatology at Hôpital Cochin from 1995 to 2018 and served as EULAR president.
Michael Doherty (rheumatologist)
Michael Doherty is a British rheumatologist and Emeritus Professor at the University of Nottingham, known for landmark osteoarthritis papers and a 2018 Lancet trial of nurse-led gout care.
Michael E. Weinblatt
Michael E. Weinblatt, also known as Michael Weinblatt, is an American rheumatologist at Brigham and Women's Hospital and Harvard Medical School known for rheumatoid arthritis drug trials.
Morris Ziff
Morris Ziff (1913–2005) was an American rheumatologist who founded the Rheumatic Diseases Division at UT Southwestern in Dallas, traced rheumatoid factor to inflamed joints, and trained 131 fellows.
Nicolino Ruperto
Nicolino Ruperto is an Italian pediatric rheumatologist who co-founded the PRINTO trials network in 1996 and became a full professor at the University of Milan-Bicocca in 2024.
Noël Fiessinger
Noël Fiessinger (1881–1946) was a French physician and professor of medicine who, with Edgar Leroy, described in 1916 the conjunctivo-urethro-synovial syndrome now called reactive arthritis.
Paul Emery
Paul Emery is a British rheumatologist, the Versus Arthritis Professor of Rheumatology at the University of Leeds, known for establishing early intervention and biologic therapy as standard in rheumatoid arthritis.
Peter E. Lipsky
Peter E. Lipsky is an American immunologist and rheumatologist known for the anti-TNF trials that established infliximab plus methotrexate for rheumatoid arthritis, and for B-cell research in lupus.
Peter K. Gregersen
Peter K. Gregersen (born 1950) is an American rheumatologist and geneticist who heads the Robert S. Boas Center for Genomics and Human Genetics in Manhasset, New York.
Peter Tugwell
Peter Tugwell is a Canadian rheumatologist and clinical epidemiologist at the University of Ottawa, known for rheumatoid arthritis trials, co-founding the Cochrane Collaboration, and health equity in evidence synthesis.
Ralph C. Williams
Ralph C. Williams Jr. (1928–2020) was an American rheumatologist known for work on rheumatoid factor and for founding rheumatology divisions at Minnesota and New Mexico.
Ravinder N. Maini
Ravinder N. Maini is a British rheumatologist who discovered that blocking TNF-alpha treats rheumatoid arthritis, creating the anti-TNF drug class, and won the 2003 Lasker Award.
Rikard Holmdahl
Rikard Holmdahl is a Swedish immunologist who studies autoimmune disease and led the positional identification of Ncf1 as a gene regulating arthritis severity in rats.
Robert J. Winchester
Robert J. Winchester is a physician and immunologist at Columbia University who proposed the shared epitope hypothesis of rheumatoid arthritis in 1987 and shared the 2013 Crafoord Prize.
Robert Landewé
Robert Landewé (Robert B M Landewé, born 1964) is a Dutch rheumatologist and clinical epidemiologist who chairs rheumatology at Zuyderland in Heerlen and co-authored the 2022 ASAS-EULAR axial spondyloarthritis guidelines.
Robert M. Plenge
Robert M. Plenge is an American rheumatologist and human geneticist who serves as chief research officer at Bristol Myers Squibb and is known for connecting rheumatoid arthritis genetics to drug discovery.
Roy Fleischmann
Roy Fleischmann is an American rheumatologist and clinical trialist at the University of Texas Southwestern Medical Center in Dallas, known for pivotal rheumatoid arthritis drug trials.
Sherine E. Gabriel
Sherine E. Gabriel is a rheumatologist and epidemiologist known for population studies of rheumatic disease and for leading Mayo Medical School, Rutgers Robert Wood Johnson Medical School, and Rush University.
Stephen M. Krane
Stephen M. Krane (1927 to 2015) was an American rheumatologist and matrix biologist at Massachusetts General Hospital and Harvard who explained how collagen-degrading enzymes destroy joints in rheumatoid arthritis.
Theodore Pincus
Theodore Pincus is an American rheumatologist and professor of medicine at Rush University in Chicago, known for the MDHAQ questionnaire, the RAPID3 index, and a 1969 DNA antibody test that made lupus diagnosis routine.
Walter Bauer
Walter Bauer was an American rheumatologist who directed the Lovett Memorial Unit at Massachusetts General Hospital, became Jackson Professor at Harvard in 1951, and died in 1963.
Yoshiya Tanaka
Yoshiya Tanaka is a Japanese rheumatologist and physician-scientist at UOEH who led the 2017 RA-BEAM phase 3 trial establishing baricitinib for rheumatoid arthritis, and has presided over major rheumatology societies.